generalized anxiety disorder
Information
- Disease name
- generalized anxiety disorder
- Disease ID
- DOID:14320
- Description
- "An anxiety disorder that is characterized by long-lasting anxiety that is not focused on any one object or situation." [url:http\://en.wikipedia.org/wiki/Anxiety_disorder]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05124639 | Active, not recruiting | N/A | Clinical Trial of a Group Self-management Support Program for Anxiety Disorders | October 6, 2022 | December 21, 2026 |
| NCT04754438 | Active, not recruiting | N/A | Comparing the Efficacy of e-CBT to Mental Health Coaching for GAD | April 1, 2021 | September 2024 |
| NCT05573672 | Active, not recruiting | Phase 2 | Dietary Counselling Plus Omega-3 Supplementation in the Treatment of Generalized Anxiety Disorder | August 12, 2022 | February 1, 2024 |
| NCT05530642 | Active, not recruiting | N/A | An Augmented Training Program for Preventing Post-Traumatic Stress Injuries Among Diverse Public Safety Personnel | September 22, 2020 | December 31, 2024 |
| NCT04931134 | Active, not recruiting | N/A | Treatment of Anxiety Disorders With Trigeminal Nerve Stimulation | February 7, 2022 | January 31, 2025 |
| NCT05330312 | Active, not recruiting | N/A | Controlled Investigation to Evaluate Impact of dCBT on Psychological Symptom Burden in Adult Subjects With PF | April 17, 2022 | November 2023 |
| NCT05157386 | Active, not recruiting | Physical Exercise as Adjunctive Therapy for Affective Disorder and Anxiety | December 20, 2021 | June 2024 | |
| NCT04751864 | Active, not recruiting | Phase 4 | Brain Stimulation & Generalized Anxiety Study | October 15, 2020 | June 21, 2021 |
| NCT04780542 | Active, not recruiting | N/A | Internet-delivered Cognitive Behavioral Treatment of Depression and Anxiety in Latin American College Students | March 1, 2021 | June 2025 |
| NCT03585010 | Active, not recruiting | N/A | Brain Response Associated With Parent-based Treatment for Childhood Anxiety Disorders | September 1, 2018 | March 31, 2024 |
| NCT03899090 | Active, not recruiting | N/A | Floatation-REST (Reduced Environmental Stimulation Therapy) for Anxiety and Depression | April 8, 2019 | May 31, 2024 |
| NCT01075672 | Active, not recruiting | N/A | Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals | January 2010 | January 2025 |
| NCT03674138 | Active, not recruiting | N/A | Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients | September 12, 2018 | October 2, 2024 |
| NCT00236067 | Completed | Phase 3 | A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder | October 2004 | March 2006 |
| NCT00266409 | Completed | Phase 4 | Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic Disorder | October 2005 | June 2006 |
| NCT00308724 | Completed | N/A | Treating Late-Life Generalized Anxiety Disorder (GAD) in Primary Care | March 2004 | April 2015 |
| NCT00322595 | Completed | Phase 3 | Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder | May 2006 | May 2007 |
| NCT00329264 | Completed | Phase 3 | Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder | April 2006 | August 2007 |
| NCT00329446 | Completed | Phase 3 | Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder | April 2006 | September 2007 |
| NCT00330174 | Completed | Phase 4 | Acamprosate in Alcoholics With Comorbid Anxiety or Depression | April 2006 | September 2010 |
| NCT00347269 | Completed | Phase 4 | Primary Care Intervention Strategy for Anxiety Disorders | June 2006 | October 2009 |
| NCT00352469 | Completed | Phase 4 | Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety | February 2006 | November 2008 |
| NCT00368745 | Completed | Phase 3 | Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use. | September 2006 | August 2008 |
| NCT00413010 | Completed | Phase 3 | Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD). | December 2006 | March 2008 |
| NCT00426426 | Completed | N/A | Comparing Cognitive Behaviour Therapy (CBT) With Metacognitive Therapy (MCT) in the Treatment of GAD | January 2007 | December 2015 |
| NCT00438386 | Completed | Phase 4 | Aripiprazole for the Treatment of Refractory Anxiety | April 2005 | June 2007 |
| NCT00456742 | Completed | Efficacy of Treatment for Generalized Anxiety Disorder | June 2006 | December 2009 | |
| NCT00481325 | Completed | Phase 2/Phase 3 | Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder | July 2007 | March 2008 |
| NCT00515242 | Completed | Phase 1/Phase 2 | Therapeutic Massage for Generalized Anxiety Disorder | September 2007 | August 2009 |
| NCT00525226 | Completed | Evaluating the Effects of Stress in Pregnancy | September 2007 | July 2012 | |
| NCT00537615 | Completed | Phase 1 | An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers | September 2007 | October 2007 |
| NCT00539357 | Completed | Phase 4 | A Pilot Study of Cranial Electrotherapy Stimulation[CES] for Generalized Anxiety Disorder | August 2005 | March 2006 |
| NCT00539578 | Completed | Phase 2 | Treatment of Patients With Anxiety Disorder (0777-022) | September 2002 | February 2003 |
| NCT00542685 | Completed | Phase 3 | A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder | October 2007 | December 2008 |
| NCT00569829 | Completed | Phase 2 | Modular Cognitive Behavioral Therapy for the Treatment of Child Anxiety Disorders in Elementary School Settings | January 2004 | June 2009 |
| NCT00579280 | Completed | Phase 4 | Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD | July 2007 | December 2010 |
| NCT00586586 | Completed | Phase 2 | Effectiveness Study of CBT for Anxiety in Children | January 2, 2008 | March 21, 2014 |
| NCT00593515 | Completed | Phase 2 | Effects of Parental Behavior on Child Anxiety Regulation | March 2000 | April 2004 |
| NCT00595231 | Completed | Phase 2 | Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD) | March 2008 | October 2008 |
| NCT00601965 | Completed | N/A | Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults | October 2007 | September 2011 |
| NCT00602212 | Completed | N/A | Virtual Reality as Anxiety Management Tool for Generalized Anxiety Disorder | February 2008 | June 2011 |
| NCT00602563 | Completed | N/A | Attention Training for Generalized Anxiety Disorder | December 2007 | June 2016 |
| NCT00613067 | Completed | N/A | ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder | December 2007 | May 2010 |
| NCT00616447 | Completed | N/A | rTMS Treatment in Patients With General Anxiety Disorder | January 2008 | November 2012 |
| NCT00616655 | Completed | Phase 2 | Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects | January 2008 | December 2008 |
| NCT00620776 | Completed | Phase 2 | Combined Treatment for Generalized Anxiety Disorder (GAD) | October 2006 | March 2008 |
| NCT00624780 | Completed | Phase 4 | Safety and Efficacy Evaluation Of Pregabalin (Lyrica) With Patients With Generalized Anxiety Disorder | May 2009 | April 2012 |
| NCT00635999 | Completed | N/A | A Comparison Between Cognitive, Behavioral, and Cognitive-Behavioral Therapy for Generalized Anxiety Disorder | October 1991 | October 1998 |
| NCT00645983 | Completed | Phase 4 | Chamomile Therapy for Generalized Anxiety | October 2005 | January 2008 |
| NCT00662259 | Completed | Phase 4 | Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety Disorder | April 2008 | September 2009 |
| NCT00662584 | Completed | Phase 3 | Repetitive Magnetic Transcranial Stimulation (rTMS) in the Treatment of Generalized Anxiety Disorder (GAD) | August 2006 | April 2007 |
| NCT00674219 | Completed | Phase 3 | Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety Disorder | May 2005 | January 2008 |
| NCT00688818 | Completed | N/A | Quetiapine in Co-Morbid Depressive and Anxiety Disorders | June 2008 | June 2013 |
| NCT00701675 | Completed | Phase 4 | Pharmacological Treatment of Generalized Anxiety Disorder in the Elderly | October 2005 | September 2009 |
| NCT00703833 | Completed | Phase 2 | A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019) | September 2002 | February 2003 |
| NCT00711737 | Completed | Study of the Changes in Metabolic Parameters in Patients Treated With Escitalopram for Six Months | September 2008 | October 2010 | |
| NCT00730691 | Completed | Phase 3 | Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder | June 2008 | February 2009 |
| NCT00731120 | Completed | Phase 3 | Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder | June 2008 | February 2009 |
| NCT00734071 | Completed | Phase 3 | An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder | June 2008 | March 2009 |
| NCT00735995 | Completed | Phase 2 | Effectiveness of Cognitive Behavioral Therapy (CBT) for Child Anxiety Disorders in Community Clinics in Norway | August 2008 | December 2013 |
| NCT00744627 | Completed | Phase 3 | Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults. | September 2008 | July 2009 |
| NCT00765219 | Completed | N/A | Cognitive Behavior Treatment of Older Adults With Generalized Anxiety Disorder in Primary Care | May 2008 | April 2015 |
| NCT00000389 | Completed | Phase 3 | Treatment for Anxiety in Children | October 1996 | November 1999 |
| NCT00787397 | Completed | N/A | Sleep, Mood, and Behavior Study | February 2009 | December 2013 |
| NCT00788034 | Completed | Phase 3 | Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety Disorder | October 2008 | July 2010 |
| NCT00803361 | Completed | Phase 3 | Duloxetine for the Treatment of Generalized Anxiety Disorder | December 2008 | January 2010 |
| NCT00902564 | Completed | Phase 4 | Escitalopram in Patients With Generalized Anxiety Disorder | March 2009 | March 2010 |
| NCT00921063 | Completed | Phase 2 | A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized Anxiety Disorder | November 2005 | July 2006 |
| NCT00938093 | Completed | N/A | Treatment of Late-life Anxiety in Primary Care Settings | March 2006 | February 2009 |
| NCT00947570 | Completed | N/A | Neural Functioning Underlying Anxiety and Its Treatment (The INSULA Study) | October 2007 | August 2012 |
| NCT00951340 | Completed | Phase 1 | Desensitization and Cognitive Therapy in General Anxiety. | July 1996 | December 1998 |
| NCT00951652 | Completed | N/A | Efficacy of Adding Interpersonal and Emotional Processing Therapy Techniques to Cognitive Behavioral Therapy to Treat Generalized Anxiety Disorder | July 1998 | December 2005 |
| NCT00953654 | Completed | N/A | Exercise Training for the Treatment of Generalized Anxiety Disorder | August 2009 | May 2010 |
| NCT00961298 | Completed | Phase 4 | An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder | September 2009 | December 2011 |
| NCT00961493 | Completed | N/A | RCT of an Acceptance-based Behavior Therapy for GAD | March 2007 | February 2013 |
| NCT01033851 | Completed | Phase 4 | Stress Reduction Techniques and Anxiety: Therapeutic and Neuroendocrine Effects | March 2008 | February 2013 |
| NCT01072344 | Completed | Phase 3 | Long Term Chamomile Therapy for Anxiety | February 2010 | June 2015 |
| NCT00774150 | Completed | N/A | Transdisciplinary Studies of CBT for Anxiety in Youth: Child Anxiety Treatment Study | October 2008 | July 2014 |
| NCT00012584 | Completed | N/A | Treatment of Youth With ADHD and Anxiety | November 2000 | May 2002 |
| NCT00044642 | Completed | Phase 4 | Lorazepam-Induced Toxicity in the Aged | December 2000 | July 2007 |
| NCT00052078 | Completed | Phase 3 | Child and Adolescent Anxiety Disorders (CAMS) | January 2003 | March 2008 |
| NCT00073632 | Completed | Phase 1 | Acceptance-Based Treatment for Generalized Anxiety Disorder | May 2002 | August 2006 |
| NCT00105586 | Completed | Phase 4 | Drug Therapy for Generalized Anxiety Disorder Among the Elderly | December 2004 | April 2008 |
| NCT00120458 | Completed | Phase 4 | Black Cohosh as Alternative Therapy for Treating Menopause-Related Anxiety | July 2005 | December 2008 |
| NCT00141115 | Completed | Phase 2 | Levetiracetam for the Treatment of Alcohol Dependence and Anxiety | March 2004 | January 2008 |
| NCT00167479 | Completed | Phase 4 | A Study of Risperidone Monotherapy in Bipolar Anxiety | September 2003 | September 2006 |
| NCT00208910 | Completed | N/A | Muscle Relaxation Therapy With Odorant Cue | November 2003 | May 2005 |
| NCT00219349 | Completed | Phase 4 | Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD) | January 2005 | July 2008 |
| NCT00235508 | Completed | Phase 4 | Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder | June 2005 | April 2006 |
| NCT00236054 | Completed | Phase 3 | A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder | October 2004 | December 2005 |
| NCT01203293 | Completed | Phase 1 | Cognitive Behavioral Therapy (CBT) for Latinos With Generalized Anxiety Disorder in the General Medical Sector | September 2009 | February 2013 |
| NCT01259596 | Completed | N/A | Telephone Psychotherapy for Late-Life Generalized Anxiety Disorder (GAD) | January 2011 | February 2015 |
| NCT01285115 | Completed | Phase 3 | The Comparative Clinical Study of Gamisoyosan on Anxiety of Generalized Anxiety Disorder According to Dosage Form | December 2008 | July 2010 |
| NCT01304862 | Completed | N/A | Electronic Self-management Resource Training for Mental Health | February 2011 | July 1, 2013 |
| NCT01311180 | Completed | Phase 2 | A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder | March 2011 | November 2012 |
| NCT01312116 | Completed | N/A | Psychodynamic Internet Treatment Versus Cognitive Behavioral Therapy (CBT) for Generalized Anxiety Disorder | January 2009 | December 2010 |
| NCT01337713 | Completed | N/A | Efficacy of Massage Therapy in the Treatment of Generalized Anxiety Disorder (GAD) | September 2010 | July 2014 |
| NCT01342120 | Completed | PHARMO Institute Seroquel Safety Study | September 2010 | November 2010 | |
| NCT01416805 | Completed | Phase 3 | Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health Centers | August 2011 | December 2015 |
| NCT01482806 | Completed | Phase 2/Phase 3 | Online Treatments for Mood and Anxiety Disorders in Primary Care | February 2012 | May 30, 2017 |
| NCT01488799 | Completed | N/A | Motivational Interviewing and Cognitive Behavioural Therapy for Generalized Anxiety Disorder | January 2012 | December 2015 |
| NCT01491880 | Completed | Phase 1/Phase 2 | Treatment Study for Rural Latino Youth With Anxiety | November 2011 | June 2013 |
| NCT01507155 | Completed | N/A | An Open Label Study of Clinical Utility and Patient Outcomes of the Genecept Assay | April 2013 | May 2014 |
| NCT01563003 | Completed | N/A | Cognitive Behavioral Therapy for Anxiety Disorders in Adolescents With Autism | June 2011 | April 2015 |
| NCT01565629 | Completed | N/A | Computer- Assisted Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders | February 2012 | October 2016 |
| NCT01570374 | Completed | N/A | Internet-based Treatment of Generalized Anxiety Disorder | January 2012 | February 2016 |
| NCT01607710 | Completed | Locating Regions of Interest in Generalized Anxiety Disorder Using Function Magnetic Resonance Imaging (fMRI) | July 2012 | June 2014 | |
| NCT01614041 | Completed | Phase 4 | Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder | January 10, 2012 | July 2019 |
| NCT01629966 | Completed | Phase 3 | Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder | June 30, 2012 | March 31, 2014 |
| NCT01659736 | Completed | N/A | Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder | May 2012 | December 2014 |
| NCT01681329 | Completed | N/A | Cognitive-Behavioral Treatment and Interpretation Modification Training for Adults With Generalized Anxiety Disorder | September 2012 | June 2018 |
| NCT01702220 | Completed | N/A | Calmer Life: Testing the Effectiveness of a Treatment for Anxiety | October 2012 | August 2015 |
| NCT01766401 | Completed | Phase 3 | Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder | January 31, 2013 | January 29, 2014 |
| NCT01844115 | Completed | Phase 3 | Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder | April 30, 2013 | March 31, 2014 |
| NCT01912287 | Completed | N/A | GATE: Generalized Anxiety - A Treatment Evaluation | December 2013 | October 25, 2019 |
| NCT01919970 | Completed | N/A | Exposure-Focused Family-Based CBT for Youth With ASD and Comorbid Anxiety | August 2013 | August 2017 |
| NCT01947647 | Completed | N/A | Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders | November 17, 2014 | December 31, 2018 |
| NCT01958788 | Completed | N/A | Testing Beliefs About Uncertainty in the Treatment of Generalized Anxiety Disorder | September 2013 | December 2014 |
| NCT01971203 | Completed | N/A | Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat | September 2009 | June 2013 |
| NCT01975480 | Completed | Phase 4 | Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other Comorbities | January 2013 | May 1, 2020 |
| NCT02028247 | Completed | N/A | Psychotherapy for Anxiety in Children With Autism Spectrum Disorder | April 2014 | October 2018 |
| NCT02051192 | Completed | Phase 1/Phase 2 | Brief Behavioral Treatment for Anxiety in Young Children | January 2014 | August 2016 |
| NCT02082561 | Completed | N/A | False Safety Behavior Elimination Therapy: A Randomized Study of a Brief Individual Transdiagnostic Treatment for Anxiety Disorders | July 2010 | September 2012 |
| NCT02096484 | Completed | N/A | A Feasibility Study of Group Metacognitive Therapy Versus Mindfulness Meditation Therapy | August 2014 | June 2016 |
| NCT02150265 | Completed | N/A | Effectiveness of Six Sessions CBT for Adolescents With Emotional Problems in Community Clinics | January 1, 2013 | March 1, 2018 |
| NCT02219880 | Completed | Phase 4 | Kava for the Treatment of Generalised Anxiety Disorder: A Double-Blind Randomised Placebo-Controlled Trial | October 13, 2015 | May 31, 2018 |
| NCT02256566 | Completed | N/A | Cognitive Training for Mood and Anxiety Disorders | September 2014 | April 20, 2016 |
| NCT02266693 | Completed | N/A | Transdiagnostic iCBT for Depression and Anxiety | August 2014 | August 2018 |
| NCT02306356 | Completed | N/A | Internet-delivered Treatment for Children With Anxiety Disorders in a Rural Area; an Open Trial in a Clinical Setting | September 2014 | October 2015 |
| NCT02552108 | Completed | N/A | A Single-Component CBT for GAD | October 2015 | October 2018 |
| NCT02615119 | Completed | N/A | Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa | October 1, 2015 | June 2023 |
| NCT02648737 | Completed | N/A | Cognitive Behavioural Therapy for Anxiety Disorders in PD | October 2016 | December 2019 |
| NCT02756507 | Completed | N/A | Transdiagnostic REBT Prevention Program for Adolescents | June 2016 | June 2018 |
| NCT02806271 | Completed | N/A | Short-Term Efficacy and Mechanisms of Change of a Worry Postponement Intervention for Generalized Anxiety Disorder | June 2016 | July 2018 |
| NCT02807480 | Completed | N/A | Approach-Avoidance Conflict-a Multi-level Predictor for Therapy Response | June 2016 | March 4, 2022 |
| NCT02810171 | Completed | N/A | Dimensional Brain Behavior Predictors of CBT Outcomes in Pediatric Anxiety | December 2016 | November 12, 2021 |
| NCT02811458 | Completed | N/A | Clinical Trial of Transdiagnostic Cognitive-Behavior Therapy for Anxiety Disorders | September 12, 2016 | July 10, 2019 |
| NCT03016052 | Completed | N/A | Visual Mismatch Negativity in Attention Bias Modifcation Treatment for Anxiety | May 2016 | October 2017 |
| NCT03051074 | Completed | N/A | Examining the Effects of Reduced Environmental Stimulation on Anxiety | December 1, 2016 | December 31, 2019 |
| NCT03072264 | Completed | N/A | Randomized Clinical Trial of a Mindfulness Based Intervention in Generalized Anxiety Disorder | October 2016 | December 2018 |
| NCT03079336 | Completed | N/A | Implementation of Psychological Treatment in Generalized Anxiety | January 2017 | May 2022 |
| NCT03099772 | Completed | N/A | CBT for GAD: Impact of Cognitive Processing on Treatment Outcome | April 2007 | March 2012 |
| NCT03113175 | Completed | N/A | Collabri Flex - Effect of Collaborative Care for People With Anxiety Disorders in General Practice | January 15, 2018 | March 29, 2021 |
| NCT03118752 | Completed | N/A | Pragmatic Collaborative Care for Cardiac Inpatients With Depression or Anxiety | October 16, 2017 | March 8, 2024 |
| NCT03143634 | Completed | Phase 1/Phase 2 | The Modular Protocol for Mental Health (MPMH) | July 18, 2017 | July 31, 2020 |
| NCT03156556 | Completed | N/A | Improving Access to the Treatment of Anxiety and Depression Among Young Adults | May 15, 2017 | January 31, 2018 |
| NCT03206437 | Completed | N/A | Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli | June 20, 2017 | November 25, 2022 |
| NCT03208348 | Completed | N/A | Pilot Study of Virtual Reality for Providing Exposure Therapy to Children | September 1, 2017 | January 31, 2018 |
| NCT03300232 | Completed | N/A | Adapting an Effective CBT for Comorbidity to a Computer-Delivered Format | April 16, 2018 | July 26, 2021 |
| NCT03414619 | Completed | N/A | The Role of Cognitive Control in the Transdiagnostic Conceptualization of "Intrusive Thoughts" | May 18, 2018 | March 6, 2020 |
| NCT03433625 | Completed | N/A | 6-Session Treatment for Generalized Anxiety Disorder | February 8, 2018 | July 1, 2020 |
| NCT03440255 | Completed | N/A | Transcutaneous Vagus Nerve Stimulation in Private Healthcare Center | July 1, 2017 | September 15, 2017 |
| NCT03458702 | Completed | N/A | The Effects of Emotional Exposure on State Anxiety | September 12, 2013 | May 2014 |
| NCT03469453 | Completed | N/A | Internet-delivered CBT for Adolescents With GAD | November 28, 2017 | August 28, 2018 |
| NCT03504475 | Completed | Phase 1 | Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers | March 29, 2018 | June 16, 2018 |
| NCT03522844 | Completed | Phase 4 | Treatments for Anxiety: Meditation and Escitalopram | June 18, 2018 | January 5, 2022 |
| NCT03591224 | Completed | N/A | Pharmacogenomic Testing to Optimize Antidepressant Drug Therapy | April 17, 2018 | December 31, 2019 |
| NCT03621371 | Completed | N/A | Cognitive-behavioral Therapy for Generalized Anxiety Disorder in Primary Care | June 15, 2018 | November 30, 2019 |
| NCT03650465 | Completed | N/A | Comparing Different CBT Approaches in GAD | May 16, 2009 | September 30, 2018 |
| NCT03709433 | Completed | N/A | Open Trial of an ACT Skills Group and Mobile App for Worry | September 17, 2018 | April 15, 2020 |
| NCT03720795 | Completed | N/A | Stepped-Care Cognitive-Behavioral Treatment for Youth With ASD and Anxiety | February 1, 2019 | December 31, 2022 |
| NCT03768544 | Completed | N/A | Self-help Guided by Lay Providers for Anxiety in Older Adults | March 11, 2019 | February 24, 2023 |
| NCT03785223 | Completed | Phase 4 | A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity | April 20, 2019 | October 31, 2022 |
| NCT03807193 | Completed | N/A | Self-selected or Predetermined Internet-based Treatment for Generalized Anxiety Disorder With Different Types of Support | February 12, 2019 | December 10, 2020 |
| NCT03819426 | Completed | N/A | Walking or High Intensity Exercise for Anxiety | December 11, 2018 | July 29, 2020 |
| NCT03829241 | Completed | Phase 3 | Randomized Trial of Adult Participants With Generalized Anxiety Disorder | February 19, 2019 | May 8, 2020 |
| NCT03925168 | Completed | N/A | Music Therapy and Dialysis: A Pilot Investigation Into the Effectiveness of Patient-Selected Music Interventions on Physiological, Psychological, and Quality-of-Life Outcomes | March 8, 2019 | January 1, 2020 |
| NCT03925987 | Completed | N/A | Predicting Treatment Response to Exposure Therapy Using Carbon Dioxide | June 7, 2018 | July 31, 2020 |
| NCT03930095 | Completed | N/A | Efficacy of an Acceptance-based Group Behavioral Therapy for Generalized Anxiety Disorder. | February 6, 2016 | August 6, 2016 |
| NCT04060940 | Completed | N/A | Emotion Regulation Therapy for Clinical Worry and Rumination | November 6, 2015 | April 26, 2022 |
| NCT04111874 | Completed | N/A | Parent-Led Cognitive-Behavioral Teletherapy for Anxiety in Youth With ASD | July 30, 2019 | December 31, 2023 |
| NCT04179526 | Completed | N/A | Transdiagnostic Internet-delivered REBT Intervention for Adolescents' Internalizing Problems | January 25, 2020 | December 30, 2022 |
| NCT04364958 | Completed | N/A | Decision Aid for Patients With Generalized Anxiety Disorder: Protocol for a Randomized Controlled Trial | May 7, 2021 | April 13, 2023 |
| NCT04421690 | Completed | N/A | Computerized Cognitive Training in Middle-Aged Adults With Generalized Anxiety Disorder: A Pilot Study | June 8, 2020 | June 30, 2022 |
| NCT04478526 | Completed | N/A | Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions | April 29, 2020 | May 1, 2021 |
| NCT04922502 | Completed | Phase 2/Phase 3 | Parent-based Treatment for Youth With Anxiety and Obsessive-compulsive Disorder | July 1, 2021 | December 22, 2023 |
| NCT05016050 | Completed | N/A | Digital Therapeutic for Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) | August 9, 2021 | April 14, 2023 |
| NCT05023759 | Completed | Anxiety Symptoms in Relation to Use of Hemp-derived, Full Spectrum Cannabidiol (CBD) | June 1, 2020 | October 31, 2020 | |
| NCT05040061 | Completed | N/A | SkillJoy Clinical Trial | May 17, 2018 | December 7, 2019 |
| NCT05108220 | Completed | Evaluation of Effects of CBD Products on Anxiety Among U.S. Women | October 15, 2020 | December 30, 2020 | |
| NCT05284435 | Completed | N/A | Internet-Based, Parent-Led Cognitive-Behavioral Therapy for Anxiety in Youth With ASD | March 28, 2022 | December 17, 2023 |
| NCT05748652 | Completed | N/A | Generalized Anxiety Therapy Effectiveness | March 6, 2023 | February 28, 2024 |
| NCT05820568 | Completed | N/A | Internet Delivered Cognitive Behavior Therapy Based on Intolerance of Uncertainty | November 2, 2022 | May 22, 2023 |
| NCT06071819 | Completed | Clinical Markers of Panic and Generalized Anxiety Disorder | August 1, 2022 | October 31, 2022 | |
| NCT06361953 | Completed | N/A | Comparing the Efficacy of Two Neurofeedback Protocols for Generalized Anxiety Disorder | June 1, 2022 | July 1, 2023 |
| NCT01118780 | Completed | Phase 4 | A Study of Duloxetine in Elderly Generalized Anxiety Disorder | October 2010 | July 2012 |
| NCT01128309 | Completed | N/A | Stress Reduction and Anxiety: Effects on the Function and Structure of the Brain | May 2010 | April 2011 |
| NCT01160588 | Completed | Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents | July 2010 | March 2015 | |
| NCT01172652 | Completed | Phase 4 | Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD) | April 2010 | October 2011 |
| NCT01178385 | Completed | Phase 2/Phase 3 | Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders | April 2010 | December 2012 |
| NCT01201967 | Completed | Phase 4 | A Collaborative Care Program to Improve Treatment of Depression and Anxiety Disorders in Cardiac Patients | September 2010 | June 2013 |
| NCT04811521 | Enrolling by invitation | N/A | Patient-centered Treatment of Anxiety After Low-Risk Chest Pain in the Emergency Room | April 1, 2021 | December 31, 2025 |
| NCT00071708 | No longer available | Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial | |||
| NCT06081348 | Not yet recruiting | Phase 2 | Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders | October 2023 | April 2024 |
| NCT06376734 | Not yet recruiting | Phase 2 | Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness | June 1, 2024 | June 1, 2030 |
| NCT05785312 | Not yet recruiting | N/A | Development of Online EMDR Therapy System and Its Comparative Testing With Face-to-Face EMDR Therapy for Treatment of Anxiety and Depressive Disorders in Pakistan | July 1, 2023 | August 1, 2025 |
| NCT05883774 | Not yet recruiting | N/A | Effects of rTMS on the Anxiety State of Older Patients With GAD | May 1, 2024 | January 1, 2025 |
| NCT06254157 | Not yet recruiting | Understanding of Participation Trends Within Generalized Anxiety Disorder Patients Involved in Clinical Trials | March 2025 | March 2027 | |
| NCT06218030 | Not yet recruiting | Phase 4 | Adjunctive Treatment With L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study | April 2024 | March 2025 |
| NCT06051721 | Not yet recruiting | Phase 1/Phase 2 | A Study of a N, N-dimethyltryptamine (DMT) Analog (CYB004) in Participants With Generalized Anxiety Disorder (GAD) With Depressive Symptoms | May 2024 | February 2025 |
| NCT06422728 | Not yet recruiting | N/A | The Effectiveness of Transdiagnostic CBT Protocol on Anxiety Disorders | June 2024 | January 2025 |
| NCT05772104 | Not yet recruiting | Phase 3 | Randomized Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder | March 10, 2023 | June 1, 2025 |
| NCT05118594 | Not yet recruiting | N/A | Testing a Precision Psychotherapy System for Low-income Patients | February 2026 | November 2026 |
| NCT05849493 | Recruiting | N/A | Effects and Mechanisms of Change of Internet Delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder | May 19, 2023 | December 31, 2026 |
| NCT06282133 | Recruiting | N/A | Behavioural Experiments for Generalized Anxiety in Adolescents - Pilot Study | February 1, 2024 | January 1, 2025 |
| NCT05749055 | Recruiting | Phase 2 | ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder | July 3, 2023 | June 2025 |
| NCT05800925 | Recruiting | Triage Survey for Psychiatry Research Eligibility | December 21, 2021 | December 31, 2025 | |
| NCT05895721 | Recruiting | N/A | Virtual Reality for Generalized Anxiety Disorders | February 21, 2023 | December 31, 2023 |
| NCT05906849 | Recruiting | N/A | Where We All Meet: ACT Approach to Adolescents Anxiety Disorders | January 1, 2023 | September 30, 2026 |
| NCT05967468 | Recruiting | N/A | Evaluation of Family-Based Behavioral Treatments for Youth With Anxiety and Obsessive-Compulsive Disorder | September 14, 2023 | March 2025 |
| NCT05970510 | Recruiting | Phase 3 | A Study to Evaluate Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets in Generalized Anxiety Disorder. | July 12, 2023 | April 30, 2026 |
| NCT06010654 | Recruiting | N/A | Pivotal RCT to Test Safety and Efficacy of Digital Therapeutics 'ANZEILAX' for Managing Generalized Anxiety Disorder | August 14, 2023 | April 4, 2024 |
| NCT06046170 | Recruiting | N/A | Adaptation and Feasibility of the Community-Based Anxiety Program Tailored for Autism (CAPTA) | January 15, 2024 | December 31, 2024 |
| NCT04225624 | Recruiting | N/A | Improving Attentional and Cognitive Control in the Psychological Treatment of Intrusive Thoughts | April 30, 2021 | March 31, 2025 |
| NCT04410575 | Recruiting | N/A | Mental Health Assessment and Prescribing by Alberta Pharmacists | March 22, 2023 | December 30, 2024 |
| NCT06124014 | Recruiting | N/A | CES for the Treatment of GAD in Young Adults | January 26, 2024 | March 2026 |
| NCT06132659 | Recruiting | N/A | Neurofeedback Enhanced Cognitive Reappraisal Training | April 22, 2024 | July 2025 |
| NCT04557891 | Recruiting | N/A | Low-Intensity Focused Ultrasound Pulsation (LIFUP) for the Treatment of Generalized Anxiety Disorder (GAD) | July 26, 2021 | December 2025 |
| NCT04793828 | Recruiting | N/A | A Transdiagnostic, Self-guided Internet Intervention ("Velibra") for Waitlist Patients With Anxiety Disorders | June 4, 2020 | December 31, 2024 |
| NCT04846777 | Recruiting | N/A | Brief Smartphone Treatment Study | November 14, 2018 | July 31, 2023 |
| NCT04900064 | Recruiting | N/A | Evaluation of Primary Care Behavioral Health (PCBH) With the Addition of Self-help CBT - A Randomized Multicenter Trial | June 14, 2021 | December 31, 2026 |
| NCT06134323 | Recruiting | N/A | Transcutaneous Vagus Nerve Stimulation for Generalized Anxiety Disorder | December 5, 2023 | September 30, 2025 |
| NCT06243614 | Recruiting | Phase 3 | Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD | July 24, 2023 | June 30, 2027 |
| NCT06243640 | Recruiting | Phase 3 | Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD | July 25, 2023 | June 30, 2027 |
| NCT05064813 | Recruiting | N/A | MBSR Mechanisms in GAD | November 1, 2021 | June 30, 2026 |
| NCT05117255 | Recruiting | N/A | Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity | January 4, 2022 | March 1, 2026 |
| NCT05203731 | Recruiting | N/A | Level of Physical Activity and Fear Learning | January 31, 2023 | January 14, 2025 |
| NCT05249543 | Recruiting | N/A | Transdiagnostic Versus Diagnosis-specific Cognitive-behavioral Therapy | March 1, 2022 | June 2024 |
| NCT06278909 | Recruiting | N/A | Trigeminal Nerve Stimulation in Treatment-resistant Generalized Anxiety Disorder: a Feasibility Study | January 18, 2024 | June 30, 2025 |
| NCT05375851 | Recruiting | N/A | Digital Interventions as an Add-on Tool in Generalized Anxiety Disorder Treatment | May 1, 2022 | February 2024 |
| NCT05393518 | Recruiting | N/A | Electroclinical Correlation of Anxiety | October 11, 2022 | October 11, 2024 |
| NCT05411302 | Recruiting | N/A | Augmenting Mental Health Support Through a Supportive Text Messaging Program | October 3, 2022 | September 1, 2025 |
| NCT05427708 | Recruiting | N/A | Respiratory Training vs Interoceptive Exposure in the Treatment of Transdiagnostic Pathological Anxiety | August 22, 2022 | May 2025 |
| NCT05467683 | Recruiting | N/A | CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy | November 2, 2022 | February 28, 2027 |
| NCT05503017 | Recruiting | N/A | Computerized Intervention Targeting the Error-Related Negativity and Balance N1 in Anxious Children | October 12, 2022 | August 2024 |
| NCT05527509 | Recruiting | N/A | Risk and Resiliency Factors in the RCMP: A Prospective Investigation | April 22, 2019 | December 2029 |
| NCT05574140 | Recruiting | BreathinG-induced Myocardial and Cerebral Perfusion in Anxiety Disorders | July 15, 2022 | September 15, 2025 | |
| NCT05671419 | Recruiting | N/A | Mindful Self-Compassion for Anxiety Disorders and Depression | January 16, 2022 | July 2026 |
| NCT05717439 | Recruiting | Feasibility and ML Training Investigation of the Senseye DT for Diagnosis of Adults With PTSD | March 1, 2023 | December 31, 2024 | |
| NCT05729373 | Recruiting | Phase 2/Phase 3 | A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder | March 8, 2023 | February 8, 2025 |
| NCT03528109 | Recruiting | N/A | Improving Access to Child Anxiety Treatment | July 1, 2018 | February 1, 2025 |
| NCT03549819 | Recruiting | Phase 3 | Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study | December 15, 2021 | February 2024 |
| NCT04512378 | Suspended | N/A | Group CBT for Intolerance of Uncertainty | February 1, 2021 | December 28, 2024 |
| NCT01815099 | Terminated | N/A | Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder | May 2014 | August 2015 |
| NCT05306977 | Terminated | N/A | rTMS Pilot for Anxiety | May 19, 2022 | August 1, 2022 |
| NCT00658762 | Terminated | Phase 3 | A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3) | May 2008 | April 2009 |
| NCT02189213 | Terminated | N/A | Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep | July 2014 | December 2019 |
| NCT04714164 | Terminated | N/A | Cognitive Behavioral Therapy Group for Older Adults Delivered by Telethealth | February 18, 2021 | September 15, 2023 |
| NCT00800280 | Terminated | Phase 1 | Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body | January 2009 | February 2009 |
| NCT03420456 | Terminated | N/A | Transcranial Pulse Near-Infrared Light in Generalized Anxiety Disorder: a Placebo-Controlled Study | September 24, 2018 | May 6, 2019 |
| NCT00735267 | Terminated | Phase 3 | A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD) | October 2008 | April 2009 |
| NCT00658008 | Terminated | Phase 3 | A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1) | April 2008 | March 2009 |
| NCT01979263 | Terminated | N/A | Attention Bias Modification Treatment for Anxious Youth | October 2013 | January 17, 2017 |
| NCT01066143 | Terminated | N/A | Generalized Anxiety and Seroquel | February 2010 | February 2013 |
| NCT00658372 | Terminated | Phase 3 | A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2) | May 2008 | March 2009 |
| NCT04901481 | Terminated | N/A | Empower Neuromodulation System - Pilot Study for Anxiety Treatment | September 17, 2021 | November 1, 2022 |
| NCT02572973 | Terminated | N/A | Acoustic Neuromodulation (ANM) for Youth With Anxiety Disorders | July 2014 | April 2016 |
| NCT00868374 | Terminated | Phase 3 | Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder | June 2008 | October 2011 |
| NCT01244711 | Terminated | Phase 4 | Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines | September 2008 | September 2011 |
| NCT04274114 | Terminated | Phase 2 | Treatment of Adults With Generalized Anxiety Disorder Using Glutamine | January 18, 2019 | May 12, 2020 |
| NCT00809536 | Terminated | Phase 1 | Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time | January 2009 | February 2009 |
| NCT00668265 | Terminated | Phase 4 | Anxiety in Recovering Opiate Dependence | January 2008 | August 2011 |
| NCT03463018 | Terminated | Phase 2 | Echinacea Angustifolia (AnxioCalm) in Anxiety | June 6, 2018 | December 15, 2021 |
| NCT03764644 | Terminated | N/A | Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders | October 2013 | July 2017 |
| NCT02310568 | Terminated | Phase 2 | POC Study in Partially Responsive Generalized Anxiety Disorder | November 2014 | October 2015 |
| NCT00374543 | Terminated | Phase 4 | Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder | February 2006 | November 2008 |
| NCT02739607 | Unknown status | N/A | Internet-delivered Transdiagnostic Intervention for Anxiety and Depression | April 2016 | March 2017 |
| NCT02476136 | Unknown status | Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis | May 2015 | December 2016 | |
| NCT03188575 | Unknown status | N/A | Effectiveness & Cost-effectiveness of Internet-delivered Interventions for Depression and Anxiety Disorders in IAPT | June 15, 2017 | August 30, 2019 |
| NCT02690441 | Unknown status | N/A | Physical Exercise Augmented CBT for GAD | March 2016 | December 2023 |
| NCT01032473 | Unknown status | Mechanisms of Sleep Disturbance in Children With Generalized Anxiety Disorder (GAD) | August 2009 | ||
| NCT03702803 | Unknown status | Phase 2 | Efficacy and Safety Study of a IMSS Developed Phytopharmaceutical for the Treatment of Anxiety. | March 16, 2016 | October 19, 2020 |
| NCT03917550 | Unknown status | N/A | RECOVERY: A Transdiagnostic Intervention for Anxiety and Depression | March 18, 2019 | March 27, 2020 |
| NCT05172427 | Unknown status | N/A | Acceptability/Feasibility of IU Intervention | September 15, 2021 | December 31, 2022 |
| NCT01570426 | Unknown status | Brain Imaging and Computer Games in Children With Either Bipolar Disorder, ADHD, Anxiety or Healthy Controls | July 2007 | December 2018 | |
| NCT03232502 | Unknown status | Phase 3 | Pharmacogenetics in Primary Care Psychotropics | August 15, 2017 | December 31, 2018 |
| NCT04433832 | Unknown status | Physical and Psychological Health Trajectories in the Context of Coronary Heart Disease | January 20, 2020 | November 30, 2023 | |
| NCT01687764 | Unknown status | N/A | Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children | August 2011 | January 2013 |
| NCT03329287 | Unknown status | N/A | Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression | July 1, 2017 | June 30, 2018 |
| NCT01906268 | Unknown status | N/A | Attention Retraining for Anxiety Disorder Patients Resistent to Antidepressants | July 2013 | |
| NCT03507114 | Unknown status | N/A | Rumination Focus Cognitive Behavior Therapy | March 27, 2018 | February 27, 2019 |
| NCT05380115 | Withdrawn | N/A | Cognitive Behavioral Therapy (CBT) for Late Life Anxiety | July 2024 | February 2025 |
| NCT00738738 | Withdrawn | Phase 3 | 6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD) | January 2009 | February 2009 |
| NCT04569760 | Withdrawn | Phase 3 | Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study | April 2021 | June 2023 |
| NCT02382224 | Withdrawn | N/A | Worry Exposure for Generalized Anxiety Disorder | September 2015 | September 2018 |
| NCT04965272 | Withdrawn | Phase 2 | A Study To Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepressant Therapies (ADTs) Compared to Placebo in Adult Participants With Generalized Anxiety Disorder (GAD) Who Have Had an Inadequate Response to ADTs Alone | August 18, 2021 | August 24, 2021 |
- Disase is a (Disease Ontology)
- DOID:2030
- Cross Reference ID (Disease Ontology)
- ICD10CM:F41.1
- Cross Reference ID (Disease Ontology)
- ICD9CM:300.02
- Cross Reference ID (Disease Ontology)
- NCI:C92622
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:192401002
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0270549
- ICD10 preferred id (Insert disease from ICD10)
- D0004560
- ICD10 class code (Insert disease from ICD10)
- F41.1